Home > Publications database > Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective > Access to Fulltext |
![]() |
|||||||
version 1 |
|